Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
N/A
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+100.00%
vs the sector median at left
MBX Biosciences, Inc. Common Stock
Market Cap
$2.68B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
N/A
Market Cap
$2.68B
Net Profit Margin
-33.44%
TTM Avg
-12.59%
3Y Avg
-3.87%
5Y Avg
-6.56%
Market Cap
$2.65B
Net Profit Margin
10.56%
TTM Avg
9.25%
3Y Avg
0.54%
5Y Avg
-8.48%
Market Cap
$2.71B
Net Profit Margin
-183.98%
TTM Avg
-2902.19%
3Y Avg
-1809.95%
5Y Avg
-1403.14%
Market Cap
$2.60B
Net Profit Margin
-0.91%
TTM Avg
-61.48%
3Y Avg
-31.69%
5Y Avg
-17.43%
Market Cap
$2.58B
Net Profit Margin
-54.75%
TTM Avg
-325.19%
3Y Avg
-290.00%
5Y Avg
-135445.82%
Market Cap
$2.78B
Net Profit Margin
22.69%
TTM Avg
19.73%
3Y Avg
-2.42%
5Y Avg
-44.65%
Market Cap
$2.57B
Net Profit Margin
1.19%
TTM Avg
0.96%
3Y Avg
0.67%
5Y Avg
-2.16%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MBX Biosciences, Inc. Common Stock (MBX) | $2.68B | 0.00% | 0.00% | 0.00% | N/A |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.68B | -33.44% | -12.59% | -3.87% | -6.56% |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.65B | 10.56% | 9.25% | 0.54% | -8.48% |
| Precigen, Inc. (PGEN)vs › | $2.71B | -183.98% | -2902.19% | -1809.95% | -1403.14% |
| AtriCure, Inc. (ATRC)vs › | $2.73B | 1.85% | -5.88% | -8.36% | -6.41% |
| Neogen Corporation (NEOG)vs › | $2.60B | -0.91% | -61.48% | -31.69% | -17.43% |
| Beam Therapeutics Inc. (BEAM)vs › | $2.58B | -54.75% | -325.19% | -290.00% | -135445.82% |
| TransMedics Group, Inc. (TMDX)vs › | $2.78B | 22.69% | 19.73% | -2.42% | -44.65% |
| Privia Health Group, Inc. (PRVA)vs › | $2.57B | 1.19% | 0.96% | 0.67% | -2.16% |
| NewAmsterdam Pharma Company N.V. (NAMS)vs › | $2.54B | -3644.21% | -718.00% | -678.45% | -452.30% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
